Literature DB >> 14585143

Chemokines in cancer.

M J Frederick1, G L Clayman.   

Abstract

Chemokines are small, chemotactic cytokines that direct migration of leukocytes, activate inflammatory responses and participate in many other pleiotropic functions, including regulation of tumour growth. Chemokines modulate tumour behaviour by three important mechanisms: regulation of tumour-associated angiogenesis, activation of a host tumour-specific immunological response, and direct stimulation of tumour cell proliferation in an autocrine fashion. All of these mechanisms are promising points of cancer intervention, and preclinical mouse models suggest that chemokine antagonists and agonists could become important in the development of new anticancer therapies.

Entities:  

Year:  2001        PMID: 14585143     DOI: 10.1017/S1462399401003301

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  14 in total

1.  Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response.

Authors:  Hsin-Hsin Peng; Shile Liang; Andrew J Henderson; Cheng Dong
Journal:  Exp Cell Res       Date:  2006-11-03       Impact factor: 3.905

2.  Melanoma cell extravasation under flow conditions is modulated by leukocytes and endogenously produced interleukin 8.

Authors:  Cheng Dong; Margaret J Slattery; Shile Liang; Hsin-Hsin Peng
Journal:  Mol Cell Biomech       Date:  2005-09

3.  Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation.

Authors:  Shile Liang; Arati Sharma; Hsin-Hsin Peng; Gavin Robertson; Cheng Dong
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

4.  Global survey of protein expression during gonadal sex determination in mice.

Authors:  Katherine Ewen; Mark Baker; Dagmar Wilhelm; R John Aitken; Peter Koopman
Journal:  Mol Cell Proteomics       Date:  2009-07-17       Impact factor: 5.911

5.  Cytokines and chemokines are expressed at different levels in small and large murine colon-26 tumors following intratumoral injections of CpG ODN.

Authors:  Sanjay Sharma; Constantine P Karakousis; Hiroshi Takita; Kyu Shin; Stephen P Brooks
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

6.  In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2.

Authors:  Klara Berencsi; Pyapalli Rani; Tianqian Zhang; Laura Gross; Michael Mastrangelo; Neal J Meropol; Dorothee Herlyn; Rajasekharan Somasundaram
Journal:  J Transl Med       Date:  2011-03-30       Impact factor: 5.531

7.  Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.

Authors:  Barbara Molon; Stefano Ugel; Federica Del Pozzo; Cristiana Soldani; Serena Zilio; Debora Avella; Antonella De Palma; Pierluigi Mauri; Ana Monegal; Maria Rescigno; Benedetta Savino; Piergiuseppe Colombo; Nives Jonjic; Sanja Pecanic; Loretta Lazzarato; Roberta Fruttero; Alberto Gasco; Vincenzo Bronte; Antonella Viola
Journal:  J Exp Med       Date:  2011-09-19       Impact factor: 14.307

8.  The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.

Authors:  Sittichai Koontongkaew
Journal:  J Cancer       Date:  2013-01-01       Impact factor: 4.207

9.  Secretion of biologically active interferon-gamma inducible protein-10 (IP-10) by Lactococcus lactis.

Authors:  Julio Villatoro-Hernandez; Maria J Loera-Arias; Anali Gamez-Escobedo; Moises Franco-Molina; Jorge G Gomez-Gutierrez; Humberto Rodriguez-Rocha; Yolanda Gutierrez-Puente; Odila Saucedo-Cardenas; Jesus Valdes-Flores; Roberto Montes-de-Oca-Luna
Journal:  Microb Cell Fact       Date:  2008-07-28       Impact factor: 5.328

10.  Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers.

Authors:  Caterina Longo; Alexis Patanarut; Tony George; Barney Bishop; Weidong Zhou; Claudia Fredolini; Mark M Ross; Virginia Espina; Giovanni Pellacani; Emanuel F Petricoin; Lance A Liotta; Alessandra Luchini
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.